| Authors: |
Gray GE; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; South African Medical Research Council, Cape Town, South Africa. Electronic address: gray@pixie.co.za., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Metch B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Bekker LG; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa., Churchyard G; Aurum Institute for Health Research, Johannesburg, South Africa., Nchabeleng M; MEDUNSA HIV Clinical Research Unit, University of Limpopo, Mankweng-E, South Africa., Mlisana K; Centre for AIDS Programme for Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Laher F; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Roux S; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa., Mngadi K; Centre for AIDS Programme for Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Innes C; Aurum Institute for Health Research, Johannesburg, South Africa., Mathebula M; MEDUNSA HIV Clinical Research Unit, University of Limpopo, Mankweng-E, South Africa., Allen M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Robertson M; Infectious Diseases and Vaccines Clinical Research, Merck and Company, North Wales, PA, USA., Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. |
